42Stockpicking

CRDF

Cardiff Oncology Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
3,7
57th %ile · 404p
P/Si
189,6
92nd %ile · 356p
EV/Salesi
177,2
92nd %ile · 356p
Div yieldi

Kursudvikling

Kun 72 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
72
Årsregnskaber
26
Peers
0/0
Valuation
3/6
Fundamentals
6/8
Datovindue
2026-02-17 til 2026-05-29

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

CRDF vurderet 2026-06-10

Score
30.7%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

62%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

33%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

61%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

55%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

17%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

29%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
54.703
Net 90d (værdi)
66.491 USD
Købere 90d
2
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.6.2026PACE GARY W▲ KØB30.00036.600 USDsec
18.6.2026Mohindru ManiChief Executive Officer▲ KØB24.70329.891 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,18-0,12-45.2%-45.2%Miss
2025Q430.1.2026-0,11-0,20+44.1%+44.1%Beat
2025Q330.10.2025-0,17-0,21+18.4%+18.4%Beat
2025Q230.7.2025-0,21-0,20-6.8%-6.8%Miss